Caxton Associates (UK)’s Enovis ENOV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-12,884
Closed -$293K 822
2026
Q1
$293K Buy
12,884
+3,007
+30% +$71.1K 0.01% 613
2025
Q4
$263K Buy
+9,877
New +$292K 0.01% 649

Other funds holding ENOV

Caxton Associates (UK)'s ENOV Position: Q2 2026 in Review

Caxton Associates (UK) sold out of Enovis (ENOV) in Q2 2026, closing a stake of 12,884 shares — an estimated $293K sold.

Caxton Associates (UK) first reported a position in ENOV in Q4 2025 and held it in 2 quarters. The position peaked at $293K in Q1 2026. 254 funds tracked by Wall St. Rank hold ENOV as of Q2 2026.

  • Caxton Associates (UK) reported no remaining Enovis position as of Q2 2026 after selling out during the quarter.
  • Caxton Associates (UK) sold 12,884 Enovis shares in Q2 2026, an estimated $293K.
  • Caxton Associates (UK) first reported a position in Enovis in Q4 2025 and held it in 2 quarters.
  • Caxton Associates (UK)'s Enovis position peaked at $293K in Q1 2026.
  • 254 funds tracked by Wall St. Rank held Enovis as of Q2 2026.

Based on Caxton Associates (UK)'s 13F filing for Q2 2026, filed 14 Aug 2026.